A case control study of melatonin with or without coenzyme Q10 in improving oocyte quality and outcomes in in vitro fertilization

Natasha Pritchard, Martin Healey, Kelli Louise Sorby, Shivanthi Sivapalan, Tiki Osianlis, Sameer Jatkar, Kerian Robinson, Farjana Sultana, Lynn Burmeister, Virochana Kaul, Beverley Janine Vollenhoven

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Antioxidant therapy is thought to improve oocyte quality through the reduction of oxidative stress. Melatonin and coenzyme Q10 (CoQ10) are known antioxidants. We aimed to investigate the clinical efficacy of exogenous melatonin supplementation with or without CoQ10 in improving oocyte quantity and quality. Fifty-three women undergoing cycles at Monash IVF were supplemented with melatonin 4mg daily, with 19 of those additionally supplemented with 150mg of CoQ10. Controls were matched at a 2:1 ratio to cases. Data were taken from an index (pretherapy) cycle and from a therapeutic (posttherapy) cycle for both cases and controls. Comparisons were made directly between cases and controls in the therapeutic cycle and by comparing the median differences of the change in outcomes from the index to therapeutic cycle. Primary outcomes included follicle, oocyte, and metaphase II oocytes (MII) counts. Results showed higher median absolute oocyte numbers (6.00 vs. 4.00, P = 0.049) in the case group. Cases and controls were significantly different when comparing median change between cycles in oocyte number (0.00 vs. -1.00, P = 0.028) and MII count (0.00 vs. -1.00, P = 0.034). However, this was the result of poorer outcomes in the control group rather than improvements in the case group, and it cannot be concluded that treatment improved oocyte quality.
Original languageEnglish
Pages (from-to)1 - 7
Number of pages7
JournalReproductive Biology Insights
Volume8
Issue number1
DOIs
Publication statusPublished - 2015

Cite this

Pritchard, Natasha ; Healey, Martin ; Sorby, Kelli Louise ; Sivapalan, Shivanthi ; Osianlis, Tiki ; Jatkar, Sameer ; Robinson, Kerian ; Sultana, Farjana ; Burmeister, Lynn ; Kaul, Virochana ; Vollenhoven, Beverley Janine. / A case control study of melatonin with or without coenzyme Q10 in improving oocyte quality and outcomes in in vitro fertilization. In: Reproductive Biology Insights. 2015 ; Vol. 8, No. 1. pp. 1 - 7.
@article{cbe307fc49f647c2b20bf6b1b37e0771,
title = "A case control study of melatonin with or without coenzyme Q10 in improving oocyte quality and outcomes in in vitro fertilization",
abstract = "Antioxidant therapy is thought to improve oocyte quality through the reduction of oxidative stress. Melatonin and coenzyme Q10 (CoQ10) are known antioxidants. We aimed to investigate the clinical efficacy of exogenous melatonin supplementation with or without CoQ10 in improving oocyte quantity and quality. Fifty-three women undergoing cycles at Monash IVF were supplemented with melatonin 4mg daily, with 19 of those additionally supplemented with 150mg of CoQ10. Controls were matched at a 2:1 ratio to cases. Data were taken from an index (pretherapy) cycle and from a therapeutic (posttherapy) cycle for both cases and controls. Comparisons were made directly between cases and controls in the therapeutic cycle and by comparing the median differences of the change in outcomes from the index to therapeutic cycle. Primary outcomes included follicle, oocyte, and metaphase II oocytes (MII) counts. Results showed higher median absolute oocyte numbers (6.00 vs. 4.00, P = 0.049) in the case group. Cases and controls were significantly different when comparing median change between cycles in oocyte number (0.00 vs. -1.00, P = 0.028) and MII count (0.00 vs. -1.00, P = 0.034). However, this was the result of poorer outcomes in the control group rather than improvements in the case group, and it cannot be concluded that treatment improved oocyte quality.",
author = "Natasha Pritchard and Martin Healey and Sorby, {Kelli Louise} and Shivanthi Sivapalan and Tiki Osianlis and Sameer Jatkar and Kerian Robinson and Farjana Sultana and Lynn Burmeister and Virochana Kaul and Vollenhoven, {Beverley Janine}",
year = "2015",
doi = "10.4137/RBI.S27776",
language = "English",
volume = "8",
pages = "1 -- 7",
journal = "Reproductive Biology Insights",
issn = "1178-6426",
publisher = "Libertas Academica",
number = "1",

}

A case control study of melatonin with or without coenzyme Q10 in improving oocyte quality and outcomes in in vitro fertilization. / Pritchard, Natasha; Healey, Martin; Sorby, Kelli Louise; Sivapalan, Shivanthi; Osianlis, Tiki; Jatkar, Sameer; Robinson, Kerian; Sultana, Farjana; Burmeister, Lynn; Kaul, Virochana; Vollenhoven, Beverley Janine.

In: Reproductive Biology Insights, Vol. 8, No. 1, 2015, p. 1 - 7.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - A case control study of melatonin with or without coenzyme Q10 in improving oocyte quality and outcomes in in vitro fertilization

AU - Pritchard, Natasha

AU - Healey, Martin

AU - Sorby, Kelli Louise

AU - Sivapalan, Shivanthi

AU - Osianlis, Tiki

AU - Jatkar, Sameer

AU - Robinson, Kerian

AU - Sultana, Farjana

AU - Burmeister, Lynn

AU - Kaul, Virochana

AU - Vollenhoven, Beverley Janine

PY - 2015

Y1 - 2015

N2 - Antioxidant therapy is thought to improve oocyte quality through the reduction of oxidative stress. Melatonin and coenzyme Q10 (CoQ10) are known antioxidants. We aimed to investigate the clinical efficacy of exogenous melatonin supplementation with or without CoQ10 in improving oocyte quantity and quality. Fifty-three women undergoing cycles at Monash IVF were supplemented with melatonin 4mg daily, with 19 of those additionally supplemented with 150mg of CoQ10. Controls were matched at a 2:1 ratio to cases. Data were taken from an index (pretherapy) cycle and from a therapeutic (posttherapy) cycle for both cases and controls. Comparisons were made directly between cases and controls in the therapeutic cycle and by comparing the median differences of the change in outcomes from the index to therapeutic cycle. Primary outcomes included follicle, oocyte, and metaphase II oocytes (MII) counts. Results showed higher median absolute oocyte numbers (6.00 vs. 4.00, P = 0.049) in the case group. Cases and controls were significantly different when comparing median change between cycles in oocyte number (0.00 vs. -1.00, P = 0.028) and MII count (0.00 vs. -1.00, P = 0.034). However, this was the result of poorer outcomes in the control group rather than improvements in the case group, and it cannot be concluded that treatment improved oocyte quality.

AB - Antioxidant therapy is thought to improve oocyte quality through the reduction of oxidative stress. Melatonin and coenzyme Q10 (CoQ10) are known antioxidants. We aimed to investigate the clinical efficacy of exogenous melatonin supplementation with or without CoQ10 in improving oocyte quantity and quality. Fifty-three women undergoing cycles at Monash IVF were supplemented with melatonin 4mg daily, with 19 of those additionally supplemented with 150mg of CoQ10. Controls were matched at a 2:1 ratio to cases. Data were taken from an index (pretherapy) cycle and from a therapeutic (posttherapy) cycle for both cases and controls. Comparisons were made directly between cases and controls in the therapeutic cycle and by comparing the median differences of the change in outcomes from the index to therapeutic cycle. Primary outcomes included follicle, oocyte, and metaphase II oocytes (MII) counts. Results showed higher median absolute oocyte numbers (6.00 vs. 4.00, P = 0.049) in the case group. Cases and controls were significantly different when comparing median change between cycles in oocyte number (0.00 vs. -1.00, P = 0.028) and MII count (0.00 vs. -1.00, P = 0.034). However, this was the result of poorer outcomes in the control group rather than improvements in the case group, and it cannot be concluded that treatment improved oocyte quality.

UR - http://www.la-press.com/a-case-control-study-of-melatonin-with-or-without-coenzyme-q10-in-impr-article-a5008

U2 - 10.4137/RBI.S27776

DO - 10.4137/RBI.S27776

M3 - Article

VL - 8

SP - 1

EP - 7

JO - Reproductive Biology Insights

JF - Reproductive Biology Insights

SN - 1178-6426

IS - 1

ER -